A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial
Autor: | Isetta, Valentina, Negrín, Miguel A., Monasterio Ponsa, Carmen, Masa, Juan F., Feu, Nuria, Álvarez, Ainhoa, Campos Rodríguez, Francisco, Ruiz, Concepción, Abad, Jorge, Vázquez-Polo, Francisco J., Farré Ventura, Ramon, Galdeano Lozano, Marina, Lloberes, Patricia, Embid, Cristina, Peña, Mónica de la, Puertas, Javier, Dalmases Cleries, Mireia, Salord, Neus, Corral, Jaime, Jurado, Bernabé, León, Carmen, Egea, Carlos, Muñoz, Aida, Parra Ordaz, Olga, Cambrodi, Roser, Martel-Escobar, María, Arqué, Meritxell, Montserrat Canal, José Ma., Spanish Sleep Network |
---|---|
Přispěvatelé: | Universitat de Barcelona |
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Pulmonary and Respiratory Medicine
Male Telemedicine medicine.medical_specialty Epidemiology medicine.medical_treatment Cost-Benefit Analysis law.invention Indirect costs Clinical trials Quality of life Randomized controlled trial law medicine Humans Continuous positive airway pressure Prospective Studies Disease management (health) Epidemiologia Telecommunication in medicine Sleep apnea syndromes Primary health care Sleep Apnea Obstructive Continuous Positive Airway Pressure business.industry Disease Management Bayes Theorem Cost-effectiveness analysis Síndromes d'apnea del son Middle Aged nervous system diseases respiratory tract diseases Clinical trial Atenció primària Physical therapy Quality of Life Patient Compliance Female business Sleep Follow-Up Studies Telecomunicació en medicina Assaigs clínics |
Zdroj: | Dipòsit Digital de la UB Universidad de Barcelona Europe PubMed Central Recercat. Dipósit de la Recerca de Catalunya instname |
Popis: | Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-based CPAP follow-up strategy with standard face-to-face management. Consecutive OSA patients requiring CPAP treatment, with sufficient internet skills and who agreed to participate, were enrolled. They were followed-up at 1, 3 and 6 months and answered surveys about sleep, CPAP side effects and lifestyle. We compared CPAP compliance, cost-effectiveness and QoL between the beginning and the end of the study. A Bayesian cost-effectiveness analysis with non-informative priors was performed. Results We randomised 139 patients. At 6 months, we found similar levels of CPAP compliance, and improved daytime sleepiness, QoL, side effects and degree of satisfaction in both groups. Despite requiring more visits, the telemedicine group was more cost-effective: costs were lower and differences in effectiveness were not relevant. Conclusions A telemedicine-based strategy for the follow-up of CPAP treatment in patients with OSA was as effective as standard hospital-based care in terms of CPAP compliance and symptom improvement, with comparable side effects and satisfaction rates. The telemedicine-based strategy had lower total costs due to savings on transport and less lost productivity (indirect costs). Trial register number NCT01716676. |
Databáze: | OpenAIRE |
Externí odkaz: |